Nucleoporin 62 and Ca(2+)/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells
- PMID: 26552607
- DOI: 10.1002/pros.23121
Nucleoporin 62 and Ca(2+)/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells
Abstract
Background: Re-activation of the transcriptional activity of the androgen receptor (AR) is an important factor mediating progression from androgen-responsive to castrate-resistant prostate cancer (CRPC). However, the mechanisms regulating AR activity in CRPC remain incompletely understood. Ca(2+) /calmodulin-dependent kinase kinase (CaMKK) 2 was previously shown to regulate AR activity in androgen-responsive prostate cancer cells. Our objective was to further explore the basis of this regulation in CRPC cells.
Methods: The abundance of CaMKK2 in nuclear fractions of androgen-responsive prostate cancer and CRPC, cells were determined by subcellular fractionation and Western blotting. CaMKK2 association with nuclear pore complexes (NPCs) and nucleoporins (Nups) including Nup62, were imaged by structured illumination and super-resolution fluorescence microscopy and co-immunoprecipitation, respectively. The abundance and subcellular localization of CaMKK2 and Nup62 in human clinical specimens of prostate cancer was visualized by immunohistochemistry. The role of Nups in the growth and viability of CRPC cells was assessed by RNA interference and cell counting. The involvement of CaMKK2 and Nup62 in regulating AR transcriptional activity was addressed by RNA interference, chromatin immunoprecipitation, androgen response element reporter assay, and Western blotting.
Results: CaMKK2 was expressed at higher levels in the nuclear fraction of CPRC C4-2 cells, than in that of androgen-responsive LNCaP cells. In C4-2 cells, CaMKK2 associated with NPCs of the nuclear envelope and physically interacted with Nup62. CaMKK2 and Nup62 demonstrated pronounced, and similar increases in both expression and perinuclear/nuclear localization in human clinical specimens of advanced prostate cancer relative to normal prostate. Knockdown of Nup62, but not of Nups, 98 or 88, reduced growth and viability of C4-2 cells. Knockdown of Nup62 produced a greater reduction of the growth and viability of C4-2 cells than of non-neoplastic RWPE-1 prostatic cells. Nup62, CaMKK2, and the AR were recruited to androgen response elements of the AR target genes, prostate specific antigen, and transmembrane protease, serine 2. Knockdown of CaMKK2 and Nup62 reduced prostate specific antigen expression and AR transcriptional activity driven by androgen response elements from the prostate-specific probasin gene promoter.
Conclusion: Nup62 and CaMKK2 are required for optimal AR transcriptional activity and a potential mechanism for AR re-activation in CRPC.
Keywords: nuclear envelope; protein phosphorylation; transcriptional activity.
© 2015 Wiley Periodicals, Inc.
Similar articles
-
A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.J Biol Chem. 2012 Jul 13;287(29):24832-43. doi: 10.1074/jbc.M112.370783. Epub 2012 May 31. J Biol Chem. 2012. PMID: 22654108 Free PMC article.
-
Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.Cancer Res. 2013 Aug 15;73(16):5066-79. doi: 10.1158/0008-5472.CAN-12-4520. Epub 2013 Jun 25. Cancer Res. 2013. PMID: 23801747
-
Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer.Prostate. 2012 Dec 1;72(16):1789-801. doi: 10.1002/pros.22533. Epub 2012 May 1. Prostate. 2012. PMID: 22549914
-
Androgen receptors in hormone-dependent and castration-resistant prostate cancer.Pharmacol Ther. 2013 Dec;140(3):223-38. doi: 10.1016/j.pharmthera.2013.07.003. Epub 2013 Jul 13. Pharmacol Ther. 2013. PMID: 23859952 Review.
-
Androgen receptor: what we know and what we expect in castration-resistant prostate cancer.Int Urol Nephrol. 2018 Oct;50(10):1753-1764. doi: 10.1007/s11255-018-1964-0. Epub 2018 Aug 20. Int Urol Nephrol. 2018. PMID: 30128923 Review.
Cited by
-
The roles of the nuclear pore complex in cellular dysfunction, aging and disease.Semin Cell Dev Biol. 2017 Aug;68:72-84. doi: 10.1016/j.semcdb.2017.05.006. Epub 2017 May 12. Semin Cell Dev Biol. 2017. PMID: 28506892 Free PMC article. Review.
-
Oncogenic potential of nucleoporins in non-hematological cancers: recent update beyond chromosome translocation and gene fusion.J Cancer Res Clin Oncol. 2019 Dec;145(12):2901-2910. doi: 10.1007/s00432-019-03063-2. Epub 2019 Oct 25. J Cancer Res Clin Oncol. 2019. PMID: 31654122 Free PMC article. Review.
-
Regulation and role of CAMKK2 in prostate cancer.Nat Rev Urol. 2022 Jun;19(6):367-380. doi: 10.1038/s41585-022-00588-z. Epub 2022 Apr 26. Nat Rev Urol. 2022. PMID: 35474107 Review.
-
Role of Calcium Signaling in Prostate Cancer Progression: Effects on Cancer Hallmarks and Bone Metastatic Mechanisms.Cancers (Basel). 2020 Apr 25;12(5):1071. doi: 10.3390/cancers12051071. Cancers (Basel). 2020. PMID: 32344908 Free PMC article. Review.
-
Overexpressed Nup88 stabilized through interaction with Nup62 promotes NF-κB dependent pathways in cancer.Front Oncol. 2023 Feb 9;13:1095046. doi: 10.3389/fonc.2023.1095046. eCollection 2023. Front Oncol. 2023. PMID: 36845732 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous